Researching ME/CFS: priority area supports researchers through grants and fellowships for collaborative ME/CFS research to address patient-led priorities and improve diagnosis, treatment and management.
Funder: UK Research and Innovation — Medical Research Council (MRC)
Due Dates: Rolling (Priority area: no closing date) | Scheme-specific deadlines (Selected MRC opportunity)
Funding Amounts: Usually up to 80% of full economic cost; MRC grants typically run 12–60 months, subject to scheme rules
Summary: Supports ME/CFS research through MRC grants and fellowships, particularly priorities identified by patients, carers and clinicians.
Key Information: Apply through an existing MRC funding opportunity relevant to your science and career stage, not directly to this priority notice.
The Medical Research Council (MRC), part of UK Research and Innovation, supports high-quality, collaborative research into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through its grant and fellowship schemes. This priority area aims to build the research portfolio and address unmet needs for better diagnosis, treatment and management. Applications addressing one or more priorities identified by the patient-, carer- and clinician-led ME/CFS Priority Setting Partnership are particularly welcome.
The programme encourages capacity building, multidisciplinary teams and partnerships with established investigators bringing relevant expertise from outside the ME/CFS field. Applicants should consider meaningful involvement of people living with ME/CFS or their representatives throughout project development. Proposals are assessed through the relevant MRC board or panel’s standard procedures, with funding prioritisation over other applications achieving the same median ranking score.